About Miroslav Gasparek
Miroslav Gasparek is CEO, Co-Founder and director at Sensible Biotechnologies.
Miroslav Gasparek first appears on SEC filings in 2023.
Experience
This experience comes from Miroslav Gasparek's profile and from SEC filings. For roles taken from filings, the years are when the filings name Miroslav Gasparek in the role, so the role may have started earlier or lasted longer.
AM
Alliance for mRNA Medicines Current
Board Member
2025 – Present
Sensible Biotechnologies, Inc. Current
CEO, Co-Founder and director
CEO and Co-Founder (2021 – Present)
2021 – Present · Oxford, Oxfordshire, United Kingdom
Develops a cell-based platform to produce mRNA for medicines.
NU
Nucleate UK
Co-founder and Managing Director
2022 – 2025
MR
Ministry of Health of the Slovak Republic
Special Advisor to the Executive Board Member of the World Health Organisation
2022 – 2024
MC
MHG Consulting
Managing Partner
2021 – 2024
NA
Nodes Advisors AG
Research Fellow
2022
SI
Stanford Existential Risks Initiative
Research Fellow
2021 – 2022
CV
Civilization Ventures
Venture Fellow
2021 – 2022
NP
Newton Venture Program
Venture Scholar
2021
UO
University of Oxford
Graduate Teaching Assistant
2020 – 2021
IP
IZP - Inštitút zdravotnej politiky
External Consultant
2020
IL
Imperial College London
BIOMOD Team Dry Lab Member
2016 – 2019
SU
Stanford University
Visiting Research Intern, Endy Lab
2018
CA
Caltech
Visiting Research Student, Murray Lab
2017
EB
Exponea (acquired by Bloomreach)
Value Delivery Consultant Intern
2016
WS
wells.sk
Co-Founder and Head of R&D
2015 – 2016
Key Colleagues at Startups
The people Miroslav Gasparek works with at each company, as listed on that company's latest Form D.
Sensible Biotechnologies, Inc. · Form D, Sep 2, 2026

Marian Kupculak
CSO, Co-Founder and director

Joel Schoppig
Partner, Oxford Science Enterprises and director

Vishal Gulati
Founder and Managing Partner, Recode Ventures, director
